Her er du: Notering / Nye aksjenoteringer / Hofseth BioCare ASA
Notering av Hofseth BioCare ASA på Oslo Axess
| Søkt notering: | 27.10.2011 | |
| Vedtatt notert: | 23.11.2011 | |
| Noteringsdato: | 02.12.2011 | |
| Ticker: | HBC | |
Hofseth BioCare’s key objective to provide high value added biomarine ingredients for human applications. The Company is founded on the core value of sustainability and optimal use of natural resources. Through innovative production technology, HBC is able to preserve the quality of protein, calcium and oil extracted from fish off-cuts. HBC is thus contributing to efficient use of marine resources and entering the higher profit market of quality ingredients for human applications.
Aksje- og selskapsdata, meldinger fra selskapet og historikk